BEARZI, ITALO
 Distribuzione geografica
Continente #
NA - Nord America 3.900
EU - Europa 2.086
AS - Asia 677
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 6.722
Nazione #
US - Stati Uniti d'America 3.889
UA - Ucraina 559
SE - Svezia 345
IE - Irlanda 284
DE - Germania 242
TR - Turchia 238
DK - Danimarca 214
IT - Italia 213
SG - Singapore 201
FI - Finlandia 122
CN - Cina 117
KR - Corea 112
GB - Regno Unito 67
CI - Costa d'Avorio 35
MA - Marocco 14
BE - Belgio 13
CA - Canada 11
FR - Francia 10
EU - Europa 8
IN - India 7
RU - Federazione Russa 6
GR - Grecia 4
NL - Olanda 3
AU - Australia 2
RS - Serbia 2
CZ - Repubblica Ceca 1
HK - Hong Kong 1
LT - Lituania 1
PK - Pakistan 1
Totale 6.722
Città #
Chandler 589
Jacksonville 564
Fairfield 349
Boardman 305
Dublin 282
Wilmington 210
Ashburn 202
Woodbridge 159
Houston 137
Ann Arbor 129
Cambridge 124
Seattle 122
San Mateo 114
Lawrence 113
Princeton 113
New York 93
Des Moines 73
Singapore 69
Centro 50
San Diego 43
Abidjan 35
Beijing 31
Venice 14
Turin 13
Brussels 11
Izmir 11
London 11
Helsinki 10
Shanghai 10
Norwalk 9
Guangzhou 7
Wuhan 6
Auburn Hills 4
Como 4
Kilburn 4
Montréal 4
Ottawa 4
Pune 4
Thessaloníki 4
Yiwu 4
Dallas 3
Mountain View 3
Pesaro 3
Porto 3
Toronto 3
Acton 2
Arzano 2
Belgrade 2
Dongyang 2
Jinhua 2
Los Angeles 2
Marche 2
Milan 2
Nanjing 2
Prescot 2
Shenzhen 2
Sydney 2
Tappahannock 2
Waanrode 2
Washington 2
Amsterdam 1
Brooklyn 1
Burlington 1
Chengdu 1
Chizhou 1
Chongqing 1
Copenhagen 1
Edinburgh 1
Euless 1
Fayetteville 1
Fiano 1
Forest City 1
Hangzhou 1
Hanover 1
Hebei 1
Jablonec nad Nisou 1
Jiaxing 1
Jining 1
Kolkata 1
Limerick 1
Liverpool 1
Morrovalle 1
Nantong 1
Napoli 1
New Bedfont 1
Ningbo 1
Nuremberg 1
Ostra 1
Qingdao 1
Quanzhou 1
Ratoath 1
Redwood City 1
Rome 1
Saint Petersburg 1
Santa Clara 1
Shaoxing 1
Simi Valley 1
Southwark 1
Stamford 1
Vallefoglia 1
Totale 4.125
Nome #
Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy. 105
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 104
Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. 97
'Secrets and lies'--the difficulties of communicating within families with inherited cancer syndromes. 93
The G/A nucleotide change at cDNA position 2494 in the E-cadherin gene (CDH1): analysis in Italian patients. 92
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. 91
Localized amyloidosis and gastrointestinal lymphoma: a rare association. 89
T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. 87
An intronic mutation in MLH1 associated with familial colon and breast cancer. 87
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. 85
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 85
Long–term follow-up in early gastric cancer: evaluation of prognostic factors. 83
[Further contribution to the ultrastructure of spleen in Cooley's disease]. 82
Anti-human versus anti-guinea pig tissue transglutaminase antibodies as the first-level serological screening test for coeliac disease in the general population. 82
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 82
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. 81
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 81
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 79
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 78
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 78
A "G insertion" at nucleic acids 481 of the H. pylori fldA gene is not associated with gastric MALT lymphoma. 77
[Ultrastructural aspects of the PAS-positive histiocytic giant cells of the spleen in Cooley's disease]. 77
Storage cells of spleen and bone marrow in thalassemia: an ultrastructural study. 76
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. 75
Significance of diffuse granularity and nodularity of the esophageal mucosa at double-contrast radiography. 73
[Effects of the conditioning with estradiol on the development of experimental amyloidosis in mice]. 72
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies. 71
Adenocarcinoma arising from ileoanal J- Pouch mucosa: An announced event? 71
Cutaneous Kikuchi's disease: report of a new case and review of the literature. 71
A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours. 70
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 70
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 70
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients. 69
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 69
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy. 69
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 69
A flow cytometric study of early gastric cancer. The detection of high proliferative activity adds important information to the prognosis. 68
Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy. 66
Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. 66
MSH2 splice site mutation and endometrial cancer. 66
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. 66
Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy. 65
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 65
Peritoneal leiomyosarcoma in a kidney transplant patient: a case report. 65
MR imaging of ulcerative colitis. 63
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 63
Gastric Dysplasia: A Ten-year Follow-up Study. 62
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. 62
Insulin-like Growth Factor (IGF) 1 and 2 help to predict disease outcome in GIST patients 61
T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature. 60
Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. 60
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC. 59
[Bronchiolo-alveolar carcinoma in the lung with scleroderma]. 59
[Radiologic aspects of the surface mucosa of the duodenal bulb. Correlation with the endoscopic and histological aspects]. 58
Synchronous mucosa-associated lymphoid tissue lymphoma and adenocarcinoma of the stomach. 57
Quantitative study of the precancerous and malignant lesions in colorectal adenomas. 57
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms. 56
Bone marrow extracellular large geometric crystals in IgG/lambda MGUS. 56
Association of thymidylate synthase polymorphisms with gastric cancer susceptibility. 56
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 55
Ampullary somatostatinoma. An immunohistochemical and ultrastructural study. 55
Gangliosides, sialoglycoproteins and glucocerebroside in the spleen and bone marrow of patients with beta-thalassemia major. 55
Centrocytic-like lymphoma associated with localized amyloidosis of the large intestine. 55
Adenoma-carcinoma sequence of colorectum. Prevalence of K-ras gene mutation in adenomas with increasing degree of dysplasia and aneuploidy. 54
Lipid-rich adenoma of the thyroid. 54
High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. 54
Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies. 54
Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis. 53
Growth-factor independence of a new differentiated hepatitis B virus DNA-negative human hepatoma cell line. 53
[Keratocysts]. 53
Gastric duplication communicating with a pancreatic duct. Report of a case. 53
Association of celiac disease and intestinal lymphomas and other cancers. 53
Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. 52
Gastrointestinal stromal tumor. A study of 158 cases: clinicopathological features and prognostic factors. 52
Gastrointestinal stromal tumors: the histology report. 52
[Cytochemical and cytogenetic study of a case of Sézary syndrome developing sarcomatous features (author's transl)]. 52
Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis. 52
Radiologic diagnosis of early gastric cancer by routine double-contrast examination. 51
Antihuman IgA tissue transglutaminase antibodies as screening test for coeliac disease 51
[Campylobacter pyloridis and gastritis: endoscopic, histological and microbiological correlations]. 51
KIT and PDGFR(alpha) mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. 50
Pleomorphic adenoma of minor salivary gland. 49
Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. 49
Multiple gastric carcinoids and pernicious anemia: report of a case. 48
[Solid pseudopapillary tumor of the pancreas. A report of 3 cases and a review of the literature]. 47
Why is coeliac disease endemic in the people of the Sahara? 47
Ultrastructural findings in the jejunal mucosa of children with IgA deficiency. 46
Basaloid carcinoma of the sigmoid colon: report of a case. 46
Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome. 45
Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients. 45
Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. 44
[Immunoblastic macroglobulinemic reticulosis: morphological cytochemical and immunological study]. 44
Maspin expression is a favorable prognostic factor in non-small cell lung cancer. 44
null 44
Small benign tumors of the esophagus: radiological diagnosis with double-contrast examination. 43
Small bowel adenocarcinoma and Crohn's disease: report of a case with differing histogenetic patterns. 43
Early gastric cancer: a morphologic study of 41 cases. 42
Traumatic rupture of nodular focal fatty infiltration of the liver: case report. 42
Intravascular bronchioloalveolar tumour. 42
Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues. 42
Totale 6.322
Categoria #
all - tutte 33.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020656 0 3 115 10 116 4 114 4 119 8 13 150
2020/20211.596 74 184 229 20 174 152 169 82 161 115 166 70
2021/2022813 44 226 8 54 5 51 32 45 46 88 39 175
2022/20231.540 131 145 106 153 161 199 4 104 382 10 119 26
2023/2024783 163 15 40 136 134 118 20 16 0 8 9 124
2024/2025272 126 146 0 0 0 0 0 0 0 0 0 0
Totale 6.839